IPF treatment SM001-055 was generally safe and improved lung function, according to top-line data from a Phase 2a trial.

As his birthday approaches, columnist Sam Kirton shares what has transpired in his life since he began this latest trip ...

Nerandomilast demonstrated it was able to outperform a placebo at improving lung function in IPF or preventing its decline ...

Many factors helped columnist Sam Kirton know when it was time to stop working so he could better attend to his health issues with IPF.

IPF's effects are relentless, says columnist Charlene Marshall, who faced various knee surgery complications because of her lung disease.

Sam Kirton started his column in November 2021 and writes from his home at Lake Anna, Virginia, where he lives with his wife Susan. His diagnosis at age 59 with idiopathic pulmonary fibrosis in ...

A University of Colorado professor has won the 2024 Alton Ochsner Award Relating Smoking and Disease for his work into how genetic and environmental factors, including smoking, contribute to a ...

Avalyn Pharma has started a Phase 2b clinical trial testing the safety and efficacy of AP01, its investigational inhaled formulation of pirfenidone, in adults with progressive pulmonary fibrosis (PF).